-
-
-
-
-
-
-
Tempest Therapeutics (TPST) Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value
-
-
-
-
-
-
-
Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights
-
-
-
-
-
-
-
Tempest Announces Appointment of Christine Pellizzari to its Board of Directors
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

